| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 17 Jun 2026 | 12 Jun 2026 |
| inter alia, 1. To consider and approve the Standalone & Consolidated Audited Financial Results of the Company for the Financial Year ended 31st March, 2026 along with the Statement of Assets and Liabilities as on that date and Cash Flow Statement for the financial year ended 31st March, 2026 and to take on record Auditor s Report thereon by the Statutory Auditors of the Company.2. To Consider and Approve the Internal Audit Report of the Company.3. Any other business with permission of the Chair, if any. QLine Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. (As Per NSE Announcement Dated on : 17.06.2026) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
